Palkar Atul V, Agrawal Abhinav, Verma Sameer, Iftikhar Asma, Miller Edmund J, Talwar Arunabh
Department of Pulmonary, Critical Care and Sleep Medicine, North Shore - LIJ Health System, New York, NY 11040, United States.
Department of Medicine, Monmouth Medical Center, Long Branch, NJ 07740, United States.
World J Respirol. 2015 Jul 28;5(2):69-77. doi: 10.5320/wjr.v5.i2.69.
Splenectomy predisposes patients to a slew of infectious and non-infectious complications including pulmonary vascular disease. Patients are at increased risk for venous thromboembolic events due to various mechanisms that may lead to chronic thromboembolic pulmonary hypertension (CTEPH). The development of CTEPH and pulmonary vasculopathy after splenectomy involves complex pathophysiologic mechanisms, some of which remain unclear. This review attempts congregate the current evidence behind our understanding about the etio-pathogenesis of pulmonary vascular disease related to splenectomy and highlight the controversies that surround its management.
脾切除术使患者易发生一系列感染性和非感染性并发症,包括肺血管疾病。由于各种可能导致慢性血栓栓塞性肺动脉高压(CTEPH)的机制,患者发生静脉血栓栓塞事件的风险增加。脾切除术后CTEPH和肺血管病变的发生涉及复杂的病理生理机制,其中一些机制尚不清楚。本综述试图汇总目前我们对脾切除术后肺血管疾病病因发病机制的理解背后的证据,并突出围绕其治疗的争议。